P

PLUS THERAPEUTICS

19 employees

Plus Therapeutics is focused on developing and delivering innovative cell-based therapies to improve the quality and length of life.

Basic info

Industry

pharmaceutical manufacturing

Sectors

PSTV
innovation
Biotechnology
rare disease
ovarian cancer
radiopharmaceutical
nanomedicine
breast cancer
drug delivery
brain cancer
oncology
liposome
healthcare
lung cancer
Nasdaq
glioblastoma
Therapeutics
radioembolization
nanotechnology
growth
Medical
cancer
liver cancer

Date founded

2019

Funding rounds raised

Total raised

$27M

from 2 investors over 2 rounds

P

PLUS THERAPEUTICS raised $18M on August 17, 2022

Investors: Cancer Prevention and Research Institute of Texas

P

PLUS THERAPEUTICS raised $27M on July 1, 2013

Investors: Oxford Finance LLC

FAQ